Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
NEW YORK, March 19, 2018 -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC healthcare products, is pleased to announce the launch of the INR Wellness immune support product line.
INR Wellness is a once-daily nutritional supplement that contains yeast, oat, and mushroom beta-glucans. These three naturally occurring beta-glucans have been shown across hundreds of clinical studies to support the human immune system and are commonly used as an OTC supplement to reduce cholesterol levels, manage blood glucose levels, and to support the immune system in people whose body defenses have been weakened by conditions such as chronic fatigue, or physical and emotional stress; or by treatments such as radiation or chemotherapy.
Immudyne’s INR Wellness product is the first in the world with a proprietary triple-action formulation that contains what we believe to be the most important beta glucans for overall immune support.
“We’re excited to add another revenue stream to Immudyne’s portfolio,” stated Justin Schreiber, President & CEO of Immudyne. “We believe INR Wellness is the highest quality immune support product on the market and presents a significant growth opportunity for the Company.”
Immudyne will begin sales of INR Wellness on Monday, March 19th, 2018 through the Company’s website. A national Facebook, Google and Amazon campaign will commence shortly thereafter.
“In 2017, the U.S. nutritional supplement and vitamin market was approximately $36.1 billion,” stated Stefan Galluppi, Chief Technology and Operating Officer of Immudyne. “The immune support vertical is an attractive segment of the supplement market that has seen little innovation in recent years. Given the extensive clinical data and proprietary formulation of INR Wellness, we believe we're well positioned for a successful product launch.”
For more information on INR Wellness or to purchase the product, please visit https://www.inrwellness.com/.
About lmmuDyne
lmmuDyne, Inc. (the "Company") is an online direct response marketing company that builds innovative and proprietary health and wellness brands that transform and enrich the lives of consumers around the world. Immudyne’s scalable and global advertising technology infrastructure leverages the world’s largest social media and online sales platforms (Facebook, Google & Amazon) to rapidly and profitably grow our continually expanding product portfolio. To learn more about our corporate strategy, brands or for investor relations please visit www.immudyne.com or email us at [email protected].
